Tandon Develops Hybrid Molecule for Breast Cancer Treatment
- Kyle Sturmann for Washington Square News April 8th, 2016
- Source: http://www.nyunews.com/2016/04/08/tandon-develops-hybrid-molecule-for-breast-cancer-treatment/
About one in eight women in the U.S. will develop breast cancer in their lifetimes. While death rates have gone down since the early 1990s, breast cancer still results in the second most deaths among women of any type of cancer, behind lung cancer. So far in 2016, researchers at NYU Langone’s Laura and Isaac Perlmutter Cancer Center and the Tandon School of Engineering have made serious strides in researching the disease.